Evidence map›Paper›PMID 29217450›Full record

ArticleMolecular metabolism2018

Cadm2 regulates body weight and energy homeostasis in mice.

Xin Yan, Zhen Wang, Vanessa Schmidt, Anton Gauert, Thomas E Willnow, Matthias Heinig, Matthew N Poy

Open access · goldAbstract read
In one paragraph

Article in Molecular metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 5 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 5 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. The genetics of cannabis lifetime use.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Genetics and epigenetics in the obesity phenotyping scenario.Reviews in endocrine & metabolic disorders · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xin YanMax Delbrück Center for Molecular Medicine, Robert Rössle Strasse 10, 13125 Berlin, Germany.
Zhen WangMax Delbrück Center for Molecular Medicine, Robert Rössle Strasse 10, 13125 Berlin, Germany.
Vanessa SchmidtMax Delbrück Center for Molecular Medicine, Robert Rössle Strasse 10, 13125 Berlin, Germany.
Anton GauertMax Delbrück Center for Molecular Medicine, Robert Rössle Strasse 10, 13125 Berlin, Germany.
Thomas E WillnowMax Delbrück Center for Molecular Medicine, Robert Rössle Strasse 10, 13125 Berlin, Germany.
Matthias HeinigHelmholtz Zentrum München, Institute of Computational Biology, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany.
Matthew N PoyMax Delbrück Center for Molecular Medicine, Robert Rössle Strasse 10, 13125 Berlin, Germany. Electronic address: matthew.poy@mdc-berlin.de.
Max Delbrück Center · DEHelmholtz Zentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveObesity is strongly linked to genes regulating neuronal signaling and function, implicating the central nervous system in the maintenance of body weight and energy metabolism. Genome-wide association studies identified significant associations between body mass index (BMI) and multiple loci near Cell adhesion molecule2 (CADM2), which encodes a mediator of synaptic signaling enriched in the brain. Here we sought to further understand the role of Cadm2 in the pathogenesis of hyperglycemia and weight gain.

methodsWe first analyzed Cadm2 expression in the brain of both human subjects and mouse models and subsequently characterized a loss-of-function mouse model of Cadm2 for alterations in glucose and energy homeostasis.

resultsWe show that the risk variant rs13078960 associates with increased CADM2 expression in the hypothalamus of human subjects. Increased Cadm2 expression in several brain regions of Lep

conclusionsTogether these data illustrate that reducing Cadm2 expression can reverse several traits associated with the metabolic syndrome including obesity, insulin resistance, and impaired glucose homeostasis.

Indexed as

Energy MetabolismAnimalsBody WeightCell Adhesion MoleculesCells, CulturedHomeostasisHumansHypothalamusInsulin ResistanceMiceMice, Inbred C57BLObesityPolymorphism, Single NucleotideCADM2 protein, humanCadm2 protein, mouseCell Adhesion MoleculesCadm2/SynCAM2Energy homeostasisGenome-wide association studiesInsulin sensitivityLeptin signaling

Identifiers

PMID29217450
PMCPMC5985021
OpenAlexW2768291874

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.